20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9915 | Eculizumab | Complement System | |
Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5 | |||
T9925 | Ofatumumab | Others | |
Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation | |||
T9927 | Panitumumab | EGFR | |
Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR). | |||
T9962 | Mepolizumab | SB 240563 | IL Receptor |
Mepolizumab (SB 240563) is a humanized monoclonal antibody neutralizing IL-5. Mepolizumab can be used in studies about severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis. | |||
T9922 | Matuzumab | EGFR | |
Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR frequently associated with the growth of blood vessels in malignancy facilitating tumor growth and survival. | |||
T76769 | Indusatumab | Guanylate cyclase | |
Indusatumab (5F9 Monoclonal antibody) is an anti-human GUCY2C (Guanylate cyclase 2C) monoclonal antibody that can be used to synthesize antibody-drug conjugate. | |||
T77480 | Bivatuzumab | BIWA 4 | Others |
Bivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6. | |||
T9913 | Ustekinumab | Interleukin | |
Ustekinumab is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody. | |||
T77374 | Ontuxizumab | MORAb-004 | Others |
Ontuxizumab (MORAb-004) is a monoclonal antibody targeting endomelanic acid with anti-tumor effects.Ontuxizumab is a potent IgG1/κ anti-endothelin (TEM-1 or CD248) monoclonal antibody for the treatment of metastatic mela... | |||
T9903 | Avelumab | PD-1/PD-L1 | |
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody. Avelumab shows potential antibody-dependent cell-mediated cytotoxicity. | |||
T77385 | Idactamab | INT-001 | |
Idactamab (INT-001) is a monoclonal antibody to the human amino acid transport protein ASCT2. | |||
T77406 | Lorvotuzumab | Others | |
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds to CD56 (NCAM1). Lorvotuzumab can be used to synthesize antibody-drug conjugate (Lorvotuzumab mertansine). | |||
T77748 | Tusamitamab | Others | |
Tusamitamab is an IgG1 monoclonal antibody targeting CEACAM5 and is the naked antibody to Tusamitamab ravtansine.Tusamitamab can be used to synthesize the antibody-activator coupling Tusamitamab ravtansine. | |||
T76891 | Oxelumab | Ro 49-89991,R 4930,huMAb OX 40L | Interleukin |
Oxelumab (R 4930) is a human monoclonal antibody for OX40L. Oxelumab could be used to study asthma. | |||
T77372 | Tisotumab | 1E10,1.00E+10 | Others |
Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody against tissue factor (TF). Tisotumab is involved in antibody-conjugating drugs that can be used to study cancer. | |||
T77129 | Belantamab | GSK2857914 | TNF |
Belantamab (GSK2857914) is a humanized IgG1 monoclonal antibody against BCMA (TNFRSF17). Belantamab is a naked antibody to Belantamab mafodotin and can be used to synthesize antibody-active molecule conjugates (Belantama... | |||
T77362 | Vorsetuzumab | SGN-70 | Immunology/Inflammation related |
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a monoclonal antibody targeting the CD70 antibody. Vorsetuzumab has anticancer activity and can enhance the macrophage-associated phagocytosis of kidney cancer cells... | |||
T77099 | Nimacimab | JNJ 2463,RYI-018 | Others |
Nimacimab is a recombinant humanized monoclonal antibody. It can improve diabetes and non-alcoholic steatohepatitis. | |||
T9901 | Adalimumab | TNF | |
Adalimumab (anti-TNF-alpha) is the first fully human recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha. | |||
T76672 | Aprutumab | FGFR-moAb,FGFR2-TTC,BAY 1179470 | FGFR |
Aprutumab (BAY 1179470) is a human FGFR2 monoclonal antibody with affinity to FGFR2 isoforms FGFR2-IIIB and FGFR2-IIIC. Aprutumab is commonly used to synthesize antibody-drug conjugates. |